Skip to Content

Humana Inc HUM Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 488.44
  • Sector Healthcare
  • Industry Healthcare Plans
  • Investment Style Large Blend
  • Day Range 485.20  –  491.45
  • Year Range 423.29  –  571.30
  • Market Cap 60.5210 Bil
  • Volume / Avg 625,542.0 /  1.3 Mil
  • Price / Sales 0.62
  • Price / Book 3.60
  • Forward Div Yield 0.80%
  • Trailing Div Yield 0.70%

Morningstar‘s Stock Analysis HUM

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Near-Term Uncertainty Creates Opportunities in Managed-Care Shares

Julie Utterback Senior Equity Analyst

Analyst Note

| Julie Utterback |

Near-term uncertainty is creating an opportunity for long-term investors in the managed-care organization segment. Of the six narrow-moat MCO stocks that we cover—Centene, Cigna, CVS Health, Elevance, Humana, and UnitedHealth—five are trading in undervalued territory, and even the typically premium-priced UnitedHealth looks reasonably valued to us.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics HUM

Company Profile HUM

Business Description

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

500 West Main Street
Louisville, KY, 40202
Industry Healthcare Plans
Employees 67,100

Related Articles HUM

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of HUM’s competitive advantage.

Humana Inc


CVS Health Corp


Centene Corp


The Cigna Group

−$3.30 (0.67%) −$0.44 (0.63%) −$1.06 (1.53%) −$3.13 (1.09%)
Market Cap
60.52 Bil88.94 Bil36.95 Bil84.18 Bil
Healthcare Plans Healthcare Plans Healthcare Plans Healthcare Plans

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Humana Inc Stock

Yes. HUM has a forward dividend yield of 0.72%. See HUM’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

HUM’s market cap is 60.52 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

HUM’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

HUM’s price/sales is 0.62.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

HUM’s price/forward earnings is 18.19.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

HUM’s price/book is 3.60.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See HUM’s valuation ratios compared to the Market Index.

HUM’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare HUM’s historical performance against its industry peers and the overall market.